Establishment Labs Holdings Inc.
Health
Performance
8.1
Risk
Sell
Buy
Curious about the Scores? Learn more.

Establishment Labs Holdings Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

04.09.2026
Red alert. Risk levels out of control.
21.08.2026
Losing steam. Not trending your way right now.
20.08.2026
Breaking down. The red game over screen is flashing.
01.01.2026
Danger zone. Balance sheet’s flashing red across the board.
ESTA
Establishment Labs Holdings Inc.
74.29
+2.75%
8.1
Sell
Buy
Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Establishment Labs Holdings Inc. do? Business model and key facts

Get the full picture of Establishment Labs Holdings Inc.: what it builds, where it operates, and how it makes money.

Establishment Labs Holdings Inc. Profile

Sector: Healthcare

Industry: Medical - Devices

Employees (FY): 1004

Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.

shop
Company facts
Fillipo Peter Caldini
CEO
1004
Employees worldwide
shop
Performance
90.34%
Last 12 months
-1.51%
Last 5 years
shop
Growth
$211.08M
Revenue year
$-51,064,000
Net income
shop
Valuation
$2.19B
Market Cap
-42.37
Price/Earnings Ratio

Stocks related to Establishment Labs Holdings Inc.

Selected based on industry alignment and relative market positioning.

UFPT
UFP Technologies, Inc.
288.79
+0.79%
7.0
Sell
Buy
UFP Technologies, Inc.
NEOG
Neogen Corporation
11.83
+1.63%
7.0
Sell
Buy
Neogen Corporation
AXGN
AxoGen, Inc.
48.28
+2.51%
5.1
Sell
Buy
AxoGen, Inc.
NVCR
Novocure Ltd
17.94
+1.70%
6.5
Sell
Buy
Novocure Ltd
INSP
Inspire Medical Systems, Inc.
63.08
+1.51%
8.2
Sell
Buy
Inspire Medical Systems, Inc.

Events and news impacting Establishment Labs Holdings Inc. stock

Earnings, coporate decisions and industry developments that can affect the share price.

Establishment Labs Holdings Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.